Purpose of Study
The purpose of this study is to investigate the effectiveness and safety of an investigation medication to reduce symptoms of major depressive disorder.

Baylor College of Medicine and the Michael E. DeBakey VA Medical Center are conducting a clinical trial in individuals between the ages of 18-65 to investigate a drug (Ezogabine) for the treatment of problems experiencing pleasure (anhedonia) in individuals currently diagnosed with depressive disorder. The study is funded by NIH and is being conducted at multiple sites nationwide.

If eligible, participants will receive the study treatments and all study-related care at no cost. Compensation will also be provided for time and travel.

To see if you qualify, please call (713) 689-9856 or

All inquiries are confidential.


Study Coordinator mood@bcm.eduPhone 1: (713) 689-9856
IRB: h-40062




Sep 27, 2017